Global disease burden attributed to unsafe sex in 204 countries and territories from 1990 to 2019: results from the Global Burden of Disease Study 2019.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
09 08 2023
Historique:
received: 06 04 2023
accepted: 03 08 2023
medline: 11 8 2023
pubmed: 10 8 2023
entrez: 9 8 2023
Statut: epublish

Résumé

Unsafe sex has become a public safety problem that endangers society, and research on deaths and disability-adjusted life years (DALYs) related to unsafe sex is valuable for global policy-making. We aimed to estimate the deaths and DALYs attributable to unsafe sex by country, gender, age group, and sociodemographic status from 1990 to 2019. We extracted data on disease burden from the Global Disease Burden 2019 (GBD 2019) database for unsafe sex, including deaths, DALYs and age-standardized rates (ASRs). Comparative analyses were performed on data about deaths, DALYs and the responding ASRs attributable to unsafe sex in different countries and regions using the Social Demographic Index (SDI). The global age-standardized mortality rate (ASMR) and age-standardized DALY rate (ASDR) attributable to unsafe sex were 11.98 (95% uncertainty intervals (UI): 10.97-13.52) per 100,000 people and 570.78 (95% UI: 510.24-658.10) per 100,000 people, respectively. Both the ASMRs and ASDRs were the highest in southern sub-Saharan Africa and lowest in Australasia and decreased with increasing SDI levels. About unsafe-sex-related disease, HIV/AIDS has the highest ASMR [8.48 (95% UI: 7.62-9.95)/100,000 people] and ASDR [447.44 (95% UI: 394.82-533.10)/100,000 people], followed by Cervical cancer [ASMR: 3.40 (95% UI: 2.90-3.81)/100,000 people and ASDR: 107.2 (95% UI: 90.52-119.43)/100,000 people] and sexually transmitted infections excluding HIV [ASMR: 0.10 (95% UI: 0.08-0.11)/100,000 people and ASDR: 16.14 (95% UI: 10.51-25.83)/100,000 people]. The death and DALY burden caused by these three diseases were more serious in the over 75 years old age group. The 40-44 age group for men and the 35-39 age group for women had the highest population of unsafe sex-related deaths and DALYs, respectively. In addition, the burden of unsafe sex in women was more serious than those in men. Unsafe sex is an important risk factor for global disease burden and a leading cause of substantial health loss. We found that the risk of ASMRs and ASDRs attributable to unsafe sex had negative correlation with SDI levels. These results demonstrate that the need for revised policies that focus on efforts to reduce overall unsafe sex worldwide.

Identifiants

pubmed: 37558737
doi: 10.1038/s41598-023-40001-2
pii: 10.1038/s41598-023-40001-2
pmc: PMC10412620
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

12900

Informations de copyright

© 2023. Springer Nature Limited.

Références

Sex Transm Infect. 2010 Apr;86(2):148-54
pubmed: 19837727
J Clin Virol. 2011 Nov;52(3):215-21
pubmed: 21880543
Nat Rev Cancer. 2018 Apr;18(4):240-254
pubmed: 29497146
J Interpers Violence. 2020 Nov;35(23-24):5574-5588
pubmed: 29294855
Arch Sex Behav. 2018 Oct;47(7):1937-1948
pubmed: 29327090
Ann Intern Med. 2019 Feb 5;170(3):ITC18-ITC32
pubmed: 30716758
J Natl Cancer Inst. 2015 Apr 29;107(6):djv086
pubmed: 25925419
PLoS Med. 2022 Jan 25;19(1):e1003861
pubmed: 35077459
Lancet HIV. 2020 Mar;7(3):e209-e214
pubmed: 32066532
Lancet. 2012 Dec 15;380(9859):2129-43
pubmed: 23245605
Curr Opin HIV AIDS. 2019 May;14(3):205-212
pubmed: 30946142
J Epidemiol Community Health. 2022 Jan 19;:
pubmed: 35046100
Stud Fam Plann. 1993 Sep-Oct;24(5):269-82
pubmed: 8296329
Lancet HIV. 2018 Aug;5(8):e438-e447
pubmed: 30025681
J Acquir Immune Defic Syndr. 2011 Sep 1;58(1):80-8
pubmed: 21637108
J Acquir Immune Defic Syndr. 2020 Aug 1;84(4):345-354
pubmed: 32598117
Lancet. 2018 Aug 25;392(10148):698-710
pubmed: 30037733
Arch Sex Behav. 2021 Feb;50(2):615-627
pubmed: 32367483
J Acquir Immune Defic Syndr. 2012 Sep 1;61(1):106-11
pubmed: 22592584
Lancet Glob Health. 2022 Dec;10(12):e1715-e1743
pubmed: 36209761
BMC Public Health. 2018 Feb 2;18(1):210
pubmed: 29394918
Lancet. 2019 Jun 15;393(10189):2428-2438
pubmed: 31056293
Nat Rev Dis Primers. 2015 Oct 01;1:15035
pubmed: 27188527
Lancet. 2016 Oct 8;388(10053):1603-1658
pubmed: 27733283
Sex Transm Dis. 2020 Jan;47(1):1-3
pubmed: 31517770
Curr Opin Immunol. 2021 Aug;71:21-26
pubmed: 33857884
Curr Psychiatry Rep. 2017 Sep 14;19(11):77
pubmed: 28905259
JAMA Oncol. 2018 Nov 1;4(11):1553-1568
pubmed: 29860482
J Infect Public Health. 2018 Jan - Feb;11(1):105-110
pubmed: 28697900
Int J Equity Health. 2020 Mar 17;19(1):39
pubmed: 32183850
Health Promot Int. 2020 Feb 1;35(1):42-49
pubmed: 30561619
Lancet Glob Health. 2020 Sep;8(9):e1106-e1107
pubmed: 32710832
Aust N Z J Public Health. 2004 Dec;28(6):549-54
pubmed: 15707204
BMC Pregnancy Childbirth. 2015 Apr 03;15:85
pubmed: 25881099
Lancet. 2022 Aug 20;400(10352):563-591
pubmed: 35988567
J Community Health. 2010 Apr;35(2):115-23
pubmed: 20012476
ScientificWorldJournal. 2022 Mar 23;2022:8110229
pubmed: 35370481
Eur J Cancer. 2005 Nov;41(17):2595-600
pubmed: 16223580
JAMA Netw Open. 2018 Sep 7;1(5):e181999
pubmed: 30646145
JAMA Oncol. 2019 Dec 1;5(12):1749-1768
pubmed: 31560378
Hum Reprod Update. 2014 Nov-Dec;20(6):952-63
pubmed: 24935861
J Womens Health (Larchmt). 2021 Dec;30(12):1667-1672
pubmed: 34871035
Lancet. 2018 Nov 17;392(10160):2203-2212
pubmed: 30195398
PLoS One. 2021 Aug 3;16(8):e0255499
pubmed: 34343216
Lancet Glob Health. 2020 Oct;8(10):e1335-e1344
pubmed: 32971056
J Int AIDS Soc. 2016 Nov 02;19(1):20992
pubmed: 27809960
CA Cancer J Clin. 2016 Nov 12;66(6):481-495
pubmed: 27314890
Inj Prev. 2020 Oct;26(Supp 1):i12-i26
pubmed: 31915273
PLoS One. 2021 Apr 8;16(4):e0249753
pubmed: 33831080
Front Immunol. 2020 Oct 28;11:590780
pubmed: 33193428
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
Int J Environ Res Public Health. 2018 Dec 24;16(1):
pubmed: 30586870

Auteurs

Pei Qiu (P)

Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta Western Rd., Xi'an, 710061, Shaan'xi, China.
School of Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi, China.

Hairong He (H)

Clinical Research Center, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.

Yuting Zhao (Y)

Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta Western Rd., Xi'an, 710061, Shaan'xi, China.
School of Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi, China.

Zejian Yang (Z)

Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta Western Rd., Xi'an, 710061, Shaan'xi, China.
School of Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi, China.

Shouyu Li (S)

Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta Western Rd., Xi'an, 710061, Shaan'xi, China.
School of Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi, China.

Peng Ni (P)

Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta Western Rd., Xi'an, 710061, Shaan'xi, China.
School of Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi, China.

Yujie Guo (Y)

School of Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi, China.

Chao Ji (C)

School of Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi, China.

Chenchen Zhang (C)

Department of Clinical Laboratory, The 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Lanzhou, China.

Huimin Zhang (H)

Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta Western Rd., Xi'an, 710061, Shaan'xi, China.

Can Zhou (C)

Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta Western Rd., Xi'an, 710061, Shaan'xi, China. zhoucanz2005@xjtufh.edu.cn.

Bo Wang (B)

Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta Western Rd., Xi'an, 710061, Shaan'xi, China. realwbo@xjtu.edu.cn.
Key Laboratory for Tumor Precision Medicine of Shaanxi Province, Xi'an, China. realwbo@xjtu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH